查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1867552

連續血糖監測系統：全球市佔率及排名、總收入及需求預測（2025-2031年）

Continuous Glucose Monitoring Systems - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024年全球連續血糖監測系統市場規模估計為122.56億美元，預計到2031年將達到314.63億美元，2025年至2031年的複合年成長率為14.1%。

本報告對近期連續血糖監測系統的關稅調整和國際戰略應對措施進行了全面評估，包括跨境產業佈局、資本配置模式、區域經濟相互依存以及供應鏈重組。

持續血糖監測儀（CGM）是一種先進的醫療設備，旨在持續監測糖尿病患者組織間液中的血糖值。這些系統通常由一個植入皮下的小型感測器組成，該感測器可將血糖值讀數無線傳輸至接收器、智慧型手機或胰島素幫浦。與傳統的指尖血糖檢測不同，CGM 可提供即時血糖值趨勢、低血糖和高血糖警報，以及用於個人化糖尿病管理的全面數據。隨著感測器技術、無線通訊和人工智慧技術的進步，CGM 正日益成為糖尿病照護以及更廣泛的數位健康、運動醫學和預防保健系統的核心組成部分。預計到 2024 年，全球持續血糖監測儀（CGM）的產量將達到約 2.89 億台，全球平均市場價格約為每台 42.4 美元。

隨著全球糖尿病患者數量的成長，持續血糖監測（CGM）系統作為一種精準智慧的血糖監測工具，正被廣泛採用。在美國和歐洲等已開發市場，不斷擴大的保險報銷政策顯著促進了第1型和第2型糖尿病患者對CGM的接受度。同時，在中國和印度等糖尿病發病率飆升的開發中國家，在數位化醫療改革和公共衛生舉措的支持下，CGM市場也在快速成長。德康醫療（Dexcom）、雅培（Abbott）Medtronic）等主要企業不斷創新，透過免校準感測器、更佳的佩戴舒適度和無縫人工智慧整合等功能，提高用戶依從性並拓展臨床應用。儘管市場前景樂觀，但仍存在一些障礙。高昂的設備成本構成了經濟承受能力的挑戰，尤其是在保險覆蓋範圍有限的市場。此外，對準確性、安全性和可靠性的嚴格要求推高了研發和製造成本。資料隱私、系統互通性和病患接受度等方面的擔憂依然存在，尤其是在CGM臨床價值仍有爭議的地區。部分市場對保險報銷的限制進一步阻礙了CGM技術的普及。此外，CGM市場高度集中，由少數幾家擁有專利和品牌優勢的全球性公司主導，這為新進入者設置了很高的進入門檻。從以醫院為基礎的醫療保健模式向以患者為中心的慢性病管理模式的轉變，推動了家庭環境和個人健康應用對CGM系統的需求。家庭監測、遠端醫療和慢性病護理平台的進步，要求CGM設備與行動應用程式、穿戴式裝置和基於人工智慧的健康服務深度整合。健身愛好者和妊娠糖尿病女性等新的使用者群體也在不斷湧現。各公司正從傳統的設備供應商轉型為數位健康生態系統供應商，建構整合硬體、平台和數據分析的閉合迴路解決方案，將CGM定位為預防性健康管理的核心要素。

本報告旨在對全球連續血糖監測系統市場按地區/國家、類型和最終用戶進行全面分析，重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名。

本報告以銷售量（千台）和收入（百萬美元）為單位，對連續血糖監測系統市場規模、估值和預測進行了呈現，以2024年為基準年，並涵蓋了2020年至2031年的歷史數據和預測數據。定量和定性分析將幫助讀者制定業務和成長策略，評估市場競爭，分析自身在當前市場中的地位，並就連續血糖監測系統做出明智的商業決策。

市場區隔

公司

  • Abbott
  • DexCom
  • Medtronic
  • Senseonics Holdings
  • Cnoga Medical
  • Meiqi Medical
  • Medtrum Technologies
  • MicroTech Medical
  • POCTech
  • SIBIONICS
  • GHA Life
  • Infinovo Medical

按類型分類的細分市場

  • 穿戴式裝置
  • 不穿戴式

最終使用者群體

  • 醫院
  • 居家醫療
  • 其他

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Continuous Glucose Monitoring Systems was estimated to be worth US$ 12256 million in 2024 and is forecast to a readjusted size of US$ 31463 million by 2031 with a CAGR of 14.1% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Continuous Glucose Monitoring Systems cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Continuous Glucose Monitoring Systems (CGM) are advanced medical devices designed to continuously track glucose levels in the interstitial fluid of diabetic patients. The system typically consists of a small sensor inserted under the skin, which transmits glucose readings wirelessly to a receiver, smartphone, or insulin pump. Unlike traditional fingerstick testing, CGM offers real-time glucose trends, alerts for hypo- or hyperglycemia, and comprehensive data for personalized diabetes management. As sensor technology, wireless communication, and AI integration advance, CGM is increasingly positioned not only for diabetes care but also as a core component in broader digital health, sports medicine, and preventive care systems. In 2024, global Continuous Glucose Monitoring Systems production reached approximately 289057 k units, with an average global market price of around US$ 42.4/unit.

With the global diabetes population continuously expanding, CGM systems are gaining widespread adoption as effective tools for precise and intelligent glucose monitoring. In developed markets like the U.S. and Europe, expanding insurance reimbursement policies are significantly boosting CGM penetration among both Type 1 and Type 2 diabetes patients. Meanwhile, developing countries such as China and India, facing surging diabetes incidence, are experiencing rapid CGM market growth supported by digital healthcare reform and public health initiatives. Leading companies including Dexcom, Abbott, and Medtronic continue to innovate through features like calibration-free sensors, improved wearability, and seamless AI integration, driving user adherence and expanding clinical applications. Despite the strong market outlook, several barriers remain. High device costs pose affordability issues, particularly in markets without sufficient insurance coverage. Additionally, stringent requirements on accuracy, safety, and reliability increase R&D and manufacturing costs. Concerns around data privacy, system interoperability, and patient adoption persist, especially in regions where CGM's clinical value is still under debate. Limited insurance reimbursement in some markets further restrains uptake. The market is also highly consolidated, dominated by a few global players with significant patent and brand advantages, creating high entry barriers for new competitors. There is a growing shift from hospital-centered care to patient-centric chronic disease management, driving demand for CGM systems in home settings and personal health applications. Home monitoring, telemedicine, and chronic care platforms are pushing CGM devices to integrate more deeply with mobile apps, wearables, and AI-based health services. New user groups such as fitness enthusiasts and women with gestational diabetes are emerging. Companies are evolving from traditional device suppliers into digital health ecosystem providers, building closed-loop solutions that combine hardware, platforms, and data analytics, and positioning CGM as a central component of proactive health management.

This report aims to provide a comprehensive presentation of the global market for Continuous Glucose Monitoring Systems, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Continuous Glucose Monitoring Systems by region & country, by Type, and by End Users.

The Continuous Glucose Monitoring Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Glucose Monitoring Systems.

Market Segmentation

By Company

  • Abbott
  • DexCom
  • Medtronic
  • Senseonics Holdings
  • Cnoga Medical
  • Meiqi Medical
  • Medtrum Technologies
  • MicroTech Medical
  • POCTech
  • SIBIONICS
  • GHA Life
  • Infinovo Medical

Segment by Type

  • Wearable
  • Non-wearable

Segment by End Users

  • Hospital
  • Home Care
  • Other

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Continuous Glucose Monitoring Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by End Users, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Continuous Glucose Monitoring Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Continuous Glucose Monitoring Systems in country level. It provides sigmate data by Type, and by End Users for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Continuous Glucose Monitoring Systems Product Introduction
  • 1.2 Global Continuous Glucose Monitoring Systems Market Size Forecast
    • 1.2.1 Global Continuous Glucose Monitoring Systems Sales Value (2020-2031)
    • 1.2.2 Global Continuous Glucose Monitoring Systems Sales Volume (2020-2031)
    • 1.2.3 Global Continuous Glucose Monitoring Systems Sales Price (2020-2031)
  • 1.3 Continuous Glucose Monitoring Systems Market Trends & Drivers
    • 1.3.1 Continuous Glucose Monitoring Systems Industry Trends
    • 1.3.2 Continuous Glucose Monitoring Systems Market Drivers & Opportunity
    • 1.3.3 Continuous Glucose Monitoring Systems Market Challenges
    • 1.3.4 Continuous Glucose Monitoring Systems Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Continuous Glucose Monitoring Systems Players Revenue Ranking (2024)
  • 2.2 Global Continuous Glucose Monitoring Systems Revenue by Company (2020-2025)
  • 2.3 Global Continuous Glucose Monitoring Systems Players Sales Volume Ranking (2024)
  • 2.4 Global Continuous Glucose Monitoring Systems Sales Volume by Company Players (2020-2025)
  • 2.5 Global Continuous Glucose Monitoring Systems Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Continuous Glucose Monitoring Systems Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Continuous Glucose Monitoring Systems Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Continuous Glucose Monitoring Systems
  • 2.9 Continuous Glucose Monitoring Systems Market Competitive Analysis
    • 2.9.1 Continuous Glucose Monitoring Systems Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Continuous Glucose Monitoring Systems Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Glucose Monitoring Systems as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Wearable
    • 3.1.2 Non-wearable
  • 3.2 Global Continuous Glucose Monitoring Systems Sales Value by Type
    • 3.2.1 Global Continuous Glucose Monitoring Systems Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Continuous Glucose Monitoring Systems Sales Value, by Type (2020-2031)
    • 3.2.3 Global Continuous Glucose Monitoring Systems Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Continuous Glucose Monitoring Systems Sales Volume by Type
    • 3.3.1 Global Continuous Glucose Monitoring Systems Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Continuous Glucose Monitoring Systems Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Continuous Glucose Monitoring Systems Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Continuous Glucose Monitoring Systems Average Price by Type (2020-2031)

4 Segmentation by End Users

  • 4.1 Introduction by End Users
    • 4.1.1 Hospital
    • 4.1.2 Home Care
    • 4.1.3 Other
  • 4.2 Global Continuous Glucose Monitoring Systems Sales Value by End Users
    • 4.2.1 Global Continuous Glucose Monitoring Systems Sales Value by End Users (2020 VS 2024 VS 2031)
    • 4.2.2 Global Continuous Glucose Monitoring Systems Sales Value, by End Users (2020-2031)
    • 4.2.3 Global Continuous Glucose Monitoring Systems Sales Value, by End Users (%) (2020-2031)
  • 4.3 Global Continuous Glucose Monitoring Systems Sales Volume by End Users
    • 4.3.1 Global Continuous Glucose Monitoring Systems Sales Volume by End Users (2020 VS 2024 VS 2031)
    • 4.3.2 Global Continuous Glucose Monitoring Systems Sales Volume, by End Users (2020-2031)
    • 4.3.3 Global Continuous Glucose Monitoring Systems Sales Volume, by End Users (%) (2020-2031)
  • 4.4 Global Continuous Glucose Monitoring Systems Average Price by End Users (2020-2031)

5 Segmentation by Region

  • 5.1 Global Continuous Glucose Monitoring Systems Sales Value by Region
    • 5.1.1 Global Continuous Glucose Monitoring Systems Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Continuous Glucose Monitoring Systems Sales Value by Region (2020-2025)
    • 5.1.3 Global Continuous Glucose Monitoring Systems Sales Value by Region (2026-2031)
    • 5.1.4 Global Continuous Glucose Monitoring Systems Sales Value by Region (%), (2020-2031)
  • 5.2 Global Continuous Glucose Monitoring Systems Sales Volume by Region
    • 5.2.1 Global Continuous Glucose Monitoring Systems Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Continuous Glucose Monitoring Systems Sales Volume by Region (2020-2025)
    • 5.2.3 Global Continuous Glucose Monitoring Systems Sales Volume by Region (2026-2031)
    • 5.2.4 Global Continuous Glucose Monitoring Systems Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Continuous Glucose Monitoring Systems Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 5.4.2 North America Continuous Glucose Monitoring Systems Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 5.5.2 Europe Continuous Glucose Monitoring Systems Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Continuous Glucose Monitoring Systems Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 5.7.2 South America Continuous Glucose Monitoring Systems Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Continuous Glucose Monitoring Systems Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Continuous Glucose Monitoring Systems Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Continuous Glucose Monitoring Systems Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Continuous Glucose Monitoring Systems Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 6.3.2 United States Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Continuous Glucose Monitoring Systems Sales Value by End Users, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 6.4.2 Europe Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Continuous Glucose Monitoring Systems Sales Value by End Users, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 6.5.2 China Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Continuous Glucose Monitoring Systems Sales Value by End Users, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 6.6.2 Japan Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Continuous Glucose Monitoring Systems Sales Value by End Users, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 6.7.2 South Korea Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Continuous Glucose Monitoring Systems Sales Value by End Users, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Continuous Glucose Monitoring Systems Sales Value by End Users, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 6.9.2 India Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Continuous Glucose Monitoring Systems Sales Value by End Users, 2024 VS 2031

7 Company Profiles

  • 7.1 Abbott
    • 7.1.1 Abbott Company Information
    • 7.1.2 Abbott Introduction and Business Overview
    • 7.1.3 Abbott Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Abbott Continuous Glucose Monitoring Systems Product Offerings
    • 7.1.5 Abbott Recent Development
  • 7.2 DexCom
    • 7.2.1 DexCom Company Information
    • 7.2.2 DexCom Introduction and Business Overview
    • 7.2.3 DexCom Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 DexCom Continuous Glucose Monitoring Systems Product Offerings
    • 7.2.5 DexCom Recent Development
  • 7.3 Medtronic
    • 7.3.1 Medtronic Company Information
    • 7.3.2 Medtronic Introduction and Business Overview
    • 7.3.3 Medtronic Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Medtronic Continuous Glucose Monitoring Systems Product Offerings
    • 7.3.5 Medtronic Recent Development
  • 7.4 Senseonics Holdings
    • 7.4.1 Senseonics Holdings Company Information
    • 7.4.2 Senseonics Holdings Introduction and Business Overview
    • 7.4.3 Senseonics Holdings Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Senseonics Holdings Continuous Glucose Monitoring Systems Product Offerings
    • 7.4.5 Senseonics Holdings Recent Development
  • 7.5 Cnoga Medical
    • 7.5.1 Cnoga Medical Company Information
    • 7.5.2 Cnoga Medical Introduction and Business Overview
    • 7.5.3 Cnoga Medical Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Cnoga Medical Continuous Glucose Monitoring Systems Product Offerings
    • 7.5.5 Cnoga Medical Recent Development
  • 7.6 Meiqi Medical
    • 7.6.1 Meiqi Medical Company Information
    • 7.6.2 Meiqi Medical Introduction and Business Overview
    • 7.6.3 Meiqi Medical Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Meiqi Medical Continuous Glucose Monitoring Systems Product Offerings
    • 7.6.5 Meiqi Medical Recent Development
  • 7.7 Medtrum Technologies
    • 7.7.1 Medtrum Technologies Company Information
    • 7.7.2 Medtrum Technologies Introduction and Business Overview
    • 7.7.3 Medtrum Technologies Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Medtrum Technologies Continuous Glucose Monitoring Systems Product Offerings
    • 7.7.5 Medtrum Technologies Recent Development
  • 7.8 MicroTech Medical
    • 7.8.1 MicroTech Medical Company Information
    • 7.8.2 MicroTech Medical Introduction and Business Overview
    • 7.8.3 MicroTech Medical Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 MicroTech Medical Continuous Glucose Monitoring Systems Product Offerings
    • 7.8.5 MicroTech Medical Recent Development
  • 7.9 POCTech
    • 7.9.1 POCTech Company Information
    • 7.9.2 POCTech Introduction and Business Overview
    • 7.9.3 POCTech Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 POCTech Continuous Glucose Monitoring Systems Product Offerings
    • 7.9.5 POCTech Recent Development
  • 7.10 SIBIONICS
    • 7.10.1 SIBIONICS Company Information
    • 7.10.2 SIBIONICS Introduction and Business Overview
    • 7.10.3 SIBIONICS Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 SIBIONICS Continuous Glucose Monitoring Systems Product Offerings
    • 7.10.5 SIBIONICS Recent Development
  • 7.11 GHA Life
    • 7.11.1 GHA Life Company Information
    • 7.11.2 GHA Life Introduction and Business Overview
    • 7.11.3 GHA Life Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 GHA Life Continuous Glucose Monitoring Systems Product Offerings
    • 7.11.5 GHA Life Recent Development
  • 7.12 Infinovo Medical
    • 7.12.1 Infinovo Medical Company Information
    • 7.12.2 Infinovo Medical Introduction and Business Overview
    • 7.12.3 Infinovo Medical Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 Infinovo Medical Continuous Glucose Monitoring Systems Product Offerings
    • 7.12.5 Infinovo Medical Recent Development

8 Industry Chain Analysis

  • 8.1 Continuous Glucose Monitoring Systems Industrial Chain
  • 8.2 Continuous Glucose Monitoring Systems Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Continuous Glucose Monitoring Systems Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Continuous Glucose Monitoring Systems Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Continuous Glucose Monitoring Systems Market Trends
  • Table 2. Continuous Glucose Monitoring Systems Market Drivers & Opportunity
  • Table 3. Continuous Glucose Monitoring Systems Market Challenges
  • Table 4. Continuous Glucose Monitoring Systems Market Restraints
  • Table 5. Global Continuous Glucose Monitoring Systems Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Continuous Glucose Monitoring Systems Revenue Market Share by Company (2020-2025)
  • Table 7. Global Continuous Glucose Monitoring Systems Sales Volume by Company (2020-2025) & (K Units)
  • Table 8. Global Continuous Glucose Monitoring Systems Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Continuous Glucose Monitoring Systems Price by Company (2020-2025) & (US$/Unit)
  • Table 10. Key Manufacturers Continuous Glucose Monitoring Systems Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Continuous Glucose Monitoring Systems Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Continuous Glucose Monitoring Systems
  • Table 13. Global Continuous Glucose Monitoring Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Glucose Monitoring Systems as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Continuous Glucose Monitoring Systems Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Continuous Glucose Monitoring Systems Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Continuous Glucose Monitoring Systems Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Continuous Glucose Monitoring Systems Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Continuous Glucose Monitoring Systems Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Continuous Glucose Monitoring Systems Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
  • Table 22. Global Continuous Glucose Monitoring Systems Sales Volume by Type (2020-2025) & (K Units)
  • Table 23. Global Continuous Glucose Monitoring Systems Sales Volume by Type (2026-2031) & (K Units)
  • Table 24. Global Continuous Glucose Monitoring Systems Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Continuous Glucose Monitoring Systems Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Continuous Glucose Monitoring Systems Price by Type (2020-2025) & (US$/Unit)
  • Table 27. Global Continuous Glucose Monitoring Systems Price by Type (2026-2031) & (US$/Unit)
  • Table 28. Global Continuous Glucose Monitoring Systems Sales Value by End Users: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Continuous Glucose Monitoring Systems Sales Value by End Users (2020-2025) & (US$ Million)
  • Table 30. Global Continuous Glucose Monitoring Systems Sales Value by End Users (2026-2031) & (US$ Million)
  • Table 31. Global Continuous Glucose Monitoring Systems Sales Market Share in Value by End Users (2020-2025)
  • Table 32. Global Continuous Glucose Monitoring Systems Sales Market Share in Value by End Users (2026-2031)
  • Table 33. Global Continuous Glucose Monitoring Systems Sales Volume by End Users: 2020 VS 2024 VS 2031 (K Units)
  • Table 34. Global Continuous Glucose Monitoring Systems Sales Volume by End Users (2020-2025) & (K Units)
  • Table 35. Global Continuous Glucose Monitoring Systems Sales Volume by End Users (2026-2031) & (K Units)
  • Table 36. Global Continuous Glucose Monitoring Systems Sales Market Share in Volume by End Users (2020-2025)
  • Table 37. Global Continuous Glucose Monitoring Systems Sales Market Share in Volume by End Users (2026-2031)
  • Table 38. Global Continuous Glucose Monitoring Systems Price by End Users (2020-2025) & (US$/Unit)
  • Table 39. Global Continuous Glucose Monitoring Systems Price by End Users (2026-2031) & (US$/Unit)
  • Table 40. Global Continuous Glucose Monitoring Systems Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Continuous Glucose Monitoring Systems Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Continuous Glucose Monitoring Systems Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Continuous Glucose Monitoring Systems Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Continuous Glucose Monitoring Systems Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Continuous Glucose Monitoring Systems Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
  • Table 46. Global Continuous Glucose Monitoring Systems Sales Volume by Region (2020-2025) & (K Units)
  • Table 47. Global Continuous Glucose Monitoring Systems Sales Volume by Region (2026-2031) & (K Units)
  • Table 48. Global Continuous Glucose Monitoring Systems Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Continuous Glucose Monitoring Systems Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Continuous Glucose Monitoring Systems Average Price by Region (2020-2025) & (US$/Unit)
  • Table 51. Global Continuous Glucose Monitoring Systems Average Price by Region (2026-2031) & (US$/Unit)
  • Table 52. Key Countries/Regions Continuous Glucose Monitoring Systems Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Continuous Glucose Monitoring Systems Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Continuous Glucose Monitoring Systems Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Continuous Glucose Monitoring Systems Sales Volume, (2020-2025) & (K Units)
  • Table 56. Key Countries/Regions Continuous Glucose Monitoring Systems Sales Volume, (2026-2031) & (K Units)
  • Table 57. Abbott Company Information
  • Table 58. Abbott Introduction and Business Overview
  • Table 59. Abbott Continuous Glucose Monitoring Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 60. Abbott Continuous Glucose Monitoring Systems Product Offerings
  • Table 61. Abbott Recent Development
  • Table 62. DexCom Company Information
  • Table 63. DexCom Introduction and Business Overview
  • Table 64. DexCom Continuous Glucose Monitoring Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 65. DexCom Continuous Glucose Monitoring Systems Product Offerings
  • Table 66. DexCom Recent Development
  • Table 67. Medtronic Company Information
  • Table 68. Medtronic Introduction and Business Overview
  • Table 69. Medtronic Continuous Glucose Monitoring Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 70. Medtronic Continuous Glucose Monitoring Systems Product Offerings
  • Table 71. Medtronic Recent Development
  • Table 72. Senseonics Holdings Company Information
  • Table 73. Senseonics Holdings Introduction and Business Overview
  • Table 74. Senseonics Holdings Continuous Glucose Monitoring Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 75. Senseonics Holdings Continuous Glucose Monitoring Systems Product Offerings
  • Table 76. Senseonics Holdings Recent Development
  • Table 77. Cnoga Medical Company Information
  • Table 78. Cnoga Medical Introduction and Business Overview
  • Table 79. Cnoga Medical Continuous Glucose Monitoring Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 80. Cnoga Medical Continuous Glucose Monitoring Systems Product Offerings
  • Table 81. Cnoga Medical Recent Development
  • Table 82. Meiqi Medical Company Information
  • Table 83. Meiqi Medical Introduction and Business Overview
  • Table 84. Meiqi Medical Continuous Glucose Monitoring Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 85. Meiqi Medical Continuous Glucose Monitoring Systems Product Offerings
  • Table 86. Meiqi Medical Recent Development
  • Table 87. Medtrum Technologies Company Information
  • Table 88. Medtrum Technologies Introduction and Business Overview
  • Table 89. Medtrum Technologies Continuous Glucose Monitoring Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 90. Medtrum Technologies Continuous Glucose Monitoring Systems Product Offerings
  • Table 91. Medtrum Technologies Recent Development
  • Table 92. MicroTech Medical Company Information
  • Table 93. MicroTech Medical Introduction and Business Overview
  • Table 94. MicroTech Medical Continuous Glucose Monitoring Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 95. MicroTech Medical Continuous Glucose Monitoring Systems Product Offerings
  • Table 96. MicroTech Medical Recent Development
  • Table 97. POCTech Company Information
  • Table 98. POCTech Introduction and Business Overview
  • Table 99. POCTech Continuous Glucose Monitoring Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 100. POCTech Continuous Glucose Monitoring Systems Product Offerings
  • Table 101. POCTech Recent Development
  • Table 102. SIBIONICS Company Information
  • Table 103. SIBIONICS Introduction and Business Overview
  • Table 104. SIBIONICS Continuous Glucose Monitoring Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 105. SIBIONICS Continuous Glucose Monitoring Systems Product Offerings
  • Table 106. SIBIONICS Recent Development
  • Table 107. GHA Life Company Information
  • Table 108. GHA Life Introduction and Business Overview
  • Table 109. GHA Life Continuous Glucose Monitoring Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 110. GHA Life Continuous Glucose Monitoring Systems Product Offerings
  • Table 111. GHA Life Recent Development
  • Table 112. Infinovo Medical Company Information
  • Table 113. Infinovo Medical Introduction and Business Overview
  • Table 114. Infinovo Medical Continuous Glucose Monitoring Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 115. Infinovo Medical Continuous Glucose Monitoring Systems Product Offerings
  • Table 116. Infinovo Medical Recent Development
  • Table 117. Key Raw Materials Lists
  • Table 118. Raw Materials Key Suppliers Lists
  • Table 119. Continuous Glucose Monitoring Systems Downstream Customers
  • Table 120. Continuous Glucose Monitoring Systems Distributors List
  • Table 121. Research Programs/Design for This Report
  • Table 122. Key Data Information from Secondary Sources
  • Table 123. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Continuous Glucose Monitoring Systems Product Picture
  • Figure 2. Global Continuous Glucose Monitoring Systems Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Continuous Glucose Monitoring Systems Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Continuous Glucose Monitoring Systems Sales Volume (2020-2031) & (K Units)
  • Figure 5. Global Continuous Glucose Monitoring Systems Sales Price (2020-2031) & (US$/Unit)
  • Figure 6. Continuous Glucose Monitoring Systems Report Years Considered
  • Figure 7. Global Continuous Glucose Monitoring Systems Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Continuous Glucose Monitoring Systems Players Sales Volume Ranking (2024) & (K Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Continuous Glucose Monitoring Systems Revenue in 2024
  • Figure 10. Continuous Glucose Monitoring Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Wearable Picture
  • Figure 12. Non-wearable Picture
  • Figure 13. Global Continuous Glucose Monitoring Systems Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Continuous Glucose Monitoring Systems Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Continuous Glucose Monitoring Systems Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
  • Figure 16. Global Continuous Glucose Monitoring Systems Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Continuous Glucose Monitoring Systems Price by Type (2020-2031) & (US$/Unit)
  • Figure 18. Product Picture of Hospital
  • Figure 19. Product Picture of Home Care
  • Figure 20. Product Picture of Other
  • Figure 21. Global Continuous Glucose Monitoring Systems Sales Value by End Users (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Continuous Glucose Monitoring Systems Sales Value Market Share by End Users, 2024 & 2031
  • Figure 23. Global Continuous Glucose Monitoring Systems Sales Volume by End Users (2020 VS 2024 VS 2031) & (K Units)
  • Figure 24. Global Continuous Glucose Monitoring Systems Sales Volume Market Share by End Users, 2024 & 2031
  • Figure 25. Global Continuous Glucose Monitoring Systems Price by End Users (2020-2031) & (US$/Unit)
  • Figure 26. North America Continuous Glucose Monitoring Systems Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Continuous Glucose Monitoring Systems Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Continuous Glucose Monitoring Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Continuous Glucose Monitoring Systems Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Continuous Glucose Monitoring Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Continuous Glucose Monitoring Systems Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Continuous Glucose Monitoring Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Continuous Glucose Monitoring Systems Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Continuous Glucose Monitoring Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Continuous Glucose Monitoring Systems Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Continuous Glucose Monitoring Systems Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Continuous Glucose Monitoring Systems Sales Volume (%), (2020-2031)
  • Figure 38. United States Continuous Glucose Monitoring Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Continuous Glucose Monitoring Systems Sales Value by End Users (%), 2024 VS 2031
  • Figure 41. Europe Continuous Glucose Monitoring Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Continuous Glucose Monitoring Systems Sales Value by End Users (%), 2024 VS 2031
  • Figure 44. China Continuous Glucose Monitoring Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Continuous Glucose Monitoring Systems Sales Value by End Users (%), 2024 VS 2031
  • Figure 47. Japan Continuous Glucose Monitoring Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Continuous Glucose Monitoring Systems Sales Value by End Users (%), 2024 VS 2031
  • Figure 50. South Korea Continuous Glucose Monitoring Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Continuous Glucose Monitoring Systems Sales Value by End Users (%), 2024 VS 2031
  • Figure 53. Southeast Asia Continuous Glucose Monitoring Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Continuous Glucose Monitoring Systems Sales Value by End Users (%), 2024 VS 2031
  • Figure 56. India Continuous Glucose Monitoring Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Continuous Glucose Monitoring Systems Sales Value by End Users (%), 2024 VS 2031
  • Figure 59. Continuous Glucose Monitoring Systems Industrial Chain
  • Figure 60. Continuous Glucose Monitoring Systems Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed